| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INSP | Common Stock | Sale | -$1.91M | -9.39K | -9.06% | $203.33 | 94.3K | Apr 1, 2024 | By Trust | F1, F2 |
| transaction | INSP | Common Stock | Sale | -$2.19M | -10.7K | -11.34% | $204.35 | 83.6K | Apr 1, 2024 | By Trust | F2, F3 |
| transaction | INSP | Common Stock | Sale | -$2.39M | -11.6K | -13.93% | $205.27 | 71.9K | Apr 1, 2024 | By Trust | F2, F4 |
| transaction | INSP | Common Stock | Sale | -$697K | -3.38K | -4.7% | $206.19 | 68.6K | Apr 1, 2024 | By Trust | F2, F5 |
| transaction | INSP | Common Stock | Sale | -$294K | -1.42K | -2.07% | $207.25 | 67.1K | Apr 1, 2024 | By Trust | F2, F6 |
| transaction | INSP | Common Stock | Sale | -$311K | -1.49K | -2.22% | $208.34 | 65.6K | Apr 1, 2024 | By Trust | F2, F7 |
| transaction | INSP | Common Stock | Sale | -$274K | -1.31K | -2% | $209.46 | 64.3K | Apr 1, 2024 | By Trust | F2, F8 |
| transaction | INSP | Common Stock | Sale | -$48.9K | -232 | -0.36% | $210.99 | 64.1K | Apr 1, 2024 | By Trust | F2, F9 |
| transaction | INSP | Common Stock | Sale | -$93.8K | -440 | -0.69% | $213.26 | 63.7K | Apr 1, 2024 | By Trust | F2, F10 |
| holding | INSP | Common Stock | 9.69K | Apr 1, 2024 | Direct | ||||||
| holding | INSP | Common Stock | 118K | Apr 1, 2024 | By LLC | F11 | |||||
| holding | INSP | Common Stock | 116K | Apr 1, 2024 | By Family Trust | F12 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.785 to $203.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.785 to $204.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.80 to $205.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.80 to $206.775. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.825 to $207.79. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.885 to $208.80. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.19 to $209.76. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.935 to $211.06. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.03 to $213.99. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F11 | Securities held by the TPH 2022 LLC. |
| F12 | Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. |